Minna Tanner

HER-2 positive breast cancer: decreasing proportion but stable incidence in Finnish population from 1982 to 2005 (2009)

Köninki, Katri, Tanner, Minna, Auvinen, Anssi, Isola, Jorma

Abstract Introduction Classification of breast cancers according to the HER-2 oncogene status is of central importance in the selection of post-surgical therapies. A decrease in the proportion of...

Basal-like phenotype is not associated with patient survival in estrogen-receptor-negative breast cancers (2007)

Jumppanen, Mervi, Gruvberger-Saal, Sofia, Kauraniemi, Päivikki, Tanner, Minna, Bendahl, Pär-Ola, Lundin, Mikael, ...

Abstract Introduction Basal-phenotype or basal-like breast cancers are characterized by basal epithelium cytokeratin (CK5/14/17) expression, negative estrogen receptor (ER) status and distinct gene...

Cytogenetic characterization and gene expression profiling of the trastuzumab-resistant breast cancer cell line JIMT-1. (2007)

Rennstam, Karin, Jonsson, Goran, Tanner, Minna, Bendahl, Par-Ola, Staaf, Johan, Kapanen, Anita I, ...

Abstract is not available

Trastuzumab causes antibody-dependent cellular cytotoxicity-mediated growth inhibition of submacroscopic JIMT-1 breast cancer xenografts despite intrinsic drug resistance (2007)

Barok Márk (1976-) (biofizikus), Isola J, Pályi-Krekk Zsuzsanna (1974-) (biofizikus), Nagy Péter (1971-) (biofizikus), Juhász István (1956-) (bőrgyógyász, Bőrsebész, Onkológus), Kauraniemi, Päivikki, ...

Topoisomerase II{alpha} Gene Amplification Predicts Favorable Treatment Response to Tailored and Dose-Escalated Anthracycline-Based Adjuvant Chemotherapy in HER-2/neu-Amplified Breast Cancer: Scandinavian Breast Group Trial 9401. (2006)

Tanner, Minna, Isola, Jorma, Wiklund, Tom, Erikstein, Bjorn, Kellokumpu-Lehtinen, Pirkko, Malmstrom, Per, ...

Abstract is not available

Patterns of chromosomal imbalances defines subgroups of breast cancer with distinct clinical features and prognosis. A study of 305 tumors by comparative genomic hybridization. (2003)

Rennstam, Karin, Ahlstedt-Soini, Minna, Baldetorp, Bo, Bendahl, Pär-Ola, Borg, Ake, Karhu, Ritva, ...

Abstract is not available

Chromosomal translocations involving 11q13 contribute to cyclin D1 overexpression in squamous cell carcinoma of the head and neck. (2002)

Akervall, Jan, Borg, Ake, Dictor, Michael, Jin, Charlotte, Jin, Yuesheng, Tanner, Minna, ...

CCND1 amplification results in cyclin D1 overexpression. However, other unidentified genetic mechanisms contribute to enhanced gene expression. In the present study, 32 squamous cell carcinoma of the...

Characterization of 20q13 amplification in breast cancer / (1996)

Tanner, Minna.

Diss. -- Tampereen yliopisto.

Positional cloning of ZNF217 and NABC1: Genes amplified at 20q13.2 and overexpressed in breast carcinoma

Collins, Colin, Rommens, Johanna M., Kowbel, David, Godfrey, Tony, Tanner, Minna, Hwang, Soo-in, ...

We report here the molecular cloning of an ≈1-Mb region of recurrent amplification at 20q13.2 in breast cancer and other tumors and the delineation of a 260-kb common region of amplification....

Positional cloning of ZNF217 and NABC1: Genes amplified at 20q13.2 and overexpressed in breast carcinoma

Collins, Colin, Rommens, Johanna M., Kowbel, David, Godfrey, Tony, Tanner, Minna, Hwang, Soo-in, ...

We report here the molecular cloning of an ≈1-Mb region of recurrent amplification at 20q13.2 in breast cancer and other tumors and the delineation of a 260-kb common region of amplification....

Basal-like phenotype is not associated with patient survival in estrogen-receptor-negative breast cancers

Jumppanen, Mervi, Gruvberger-Saal, Sofia, Kauraniemi, Päivikki, Tanner, Minna, Bendahl, Pär-Ola, Lundin, Mikael, ...

Amplification and Deletion of Topoisomerase IIα Associate with ErbB-2 Amplification and Affect Sensitivity to Topoisomerase II Inhibitor Doxorubicin in Breast Cancer

Järvinen, Tero A. H., Tanner, Minna, Rantanen, Virpi, Bärlund, Maarit, Borg, Åke, Grénman, Seija, ...

Topoisomerase IIα (topoIIα) is a key enzyme in DNA replication and a molecular target for many anti-cancer drugs called topoII inhibitors. The topoIIα gene is located at chromosome band 17q12-q21,...

Amplification and Overexpression of p40 Subunit of Eukaryotic Translation Initiation Factor 3 in Breast and Prostate Cancer

Nupponen, Nina N., Porkka, Kati, Kakkola, Laura, Tanner, Minna, Persson, Karin, Borg, Åke, ...

Amplification at the long arm of chromosome 8 occurs in a large fraction of breast and prostate cancers. To clone the target genes for this amplification, we used suppression subtraction...

Chromogenic in Situ Hybridization : A Practical Alternative for Fluorescence in Situ Hybridization to Detect HER-2/neu Oncogene Amplification in Archival Breast Cancer Samples

Tanner, Minna, Gancberg, David, Di Leo, Angelo, Larsimont, Denis, Rouas, Ghizlane, Piccart, Martine J., ...

Determination of HER-2/neu oncogene amplification has become necessary for selection of breast cancer patients for trastuzumab (Herceptin) therapy. Fluorescence in situ hybridization (FISH) is...

HER-2 positive breast cancer: decreasing proportion but stable incidence in Finnish population from 1982 to 2005

Köninki, Katri, Tanner, Minna, Auvinen, Anssi, Isola, Jorma